e-Drug3D

837

AMPRENAVIR

DISCONTINUED

INN
AMPRENAVIR

(is an active metabolite)

cas 161814-49-9

CLASS

ANTIINFECTIVES
ENZYME INHIBITOR (HIV PROTEASE)
ANTIVIRAL

ROUTE (list)

ORAL

ATC code

J05AE05

PK parameters

Tmax 1.3 HOUR
PPB 90 PERCENT
t1/2 7.7 HOUR

Target

TARGET HIV-1 PROTEASE

PDB
4JEC (JOINT NEUTRON AND X-RAY STRUCTURE OF PER-DEUTERATED HIV-1 PROTEASE IN COMPLEX WITH CLINICAL INHIBITOR AMPRENAVIR)

Ligand code = 478 (link to the list of PDB complexes)

Download experimental 3D coordinates of 478 with added hydrogens

DrugCentral

Pol polyprotein UNIPROT Q72874 pol

Download SDF file

[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate

Formula:
C25H35N3O6S

Calculated chemical properties:

MW 505.63
NB_atoms 35
XLogP 2.40
PSA 123.124
NB_HD 4
NB_HA 9
fsp3 0.48
Lipinski(0=no;1=yes) 0

FDA
NDA 021007 (pdf not found) INN (AMPRENAVIR) AGENERASE (GLAXOSMITHKLINE) APPROVAL= AP YEAR= 1999 DISCONTINUED
NDA 021039 (pdf not found) INN (AMPRENAVIR) AGENERASE (GLAXOSMITHKLINE) APPROVAL= AP YEAR= 1999 DISCONTINUED